Education
About Us
Working with TipRanks
Follow Us
Fuso Pharmaceutical Industries,Ltd. (JP:4538)
:4538
RESEARCH TOOLSreports
Total Valuation
Fuso Pharmaceutical Industries,Ltd. has a market cap or net worth of ¥18.54B. The enterprise value is ―.
Market Cap¥18.54B
Enterprise Value―
Share Statistics
Fuso Pharmaceutical Industries,Ltd. has 9,451,169 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,451,169
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Fuso Pharmaceutical Industries,Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee40.44M
Profits Per Employee1.29M
Employee Count1,370
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Fuso Pharmaceutical Industries,Ltd. is ―. Fuso Pharmaceutical Industries,Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Fuso Pharmaceutical Industries,Ltd. had revenue of 55.41B and earned 1.38B in profits. Earnings per share was 159.92.
Revenue55.41B
Gross Profit13.52B
Operating Income1.96B
Pretax Income1.77B
Net Income1.38B
EBITDA3.67B
Earnings Per Share (EPS)159.92
Cash Flow
In the last 12 months, operating cash flow was 4.37B and capital expenditures 0.00, giving a free cash flow of 4.37B billion.
Operating Cash Flow4.37B
Free Cash Flow4.37B
Free Cash Flow per Share462.17
Dividends & Yields
Fuso Pharmaceutical Industries,Ltd. pays an annual dividend of ¥82, resulting in a dividend yield of 3.96%
Dividend Per Share¥82
Dividend Yield3.96%
Payout Ratio25.20%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.59
52-Week Price Change-10.24%
50-Day Moving Average2.22K
200-Day Moving Average2.36K
Relative Strength Index (RSI)38.99
Average Volume (3m)17.39K
Important Dates
Fuso Pharmaceutical Industries,Ltd. upcoming earnings date is Aug 7, 2025, TBA (Confirmed).
Last Earnings DateMay 9, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
Fuso Pharmaceutical Industries,Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Fuso Pharmaceutical Industries,Ltd. has paid 389.00M in taxes.
Income Tax389.00M
Effective Tax Rate―
Enterprise Valuation
Fuso Pharmaceutical Industries,Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Fuso Pharmaceutical Industries,Ltd. has ¥6.68B in cash and marketable securities with ¥14.28B in debt, giving a net cash position of ¥7.60B billion.
Cash & Marketable Securities¥6.68B
Total Debt¥14.28B
Net Cash¥7.60B
Net Cash Per Share¥804.03
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Fuso Pharmaceutical Industries,Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.31%
EPS Growth Forecast-340.82%